Mohali

Walk in interview for M Pharm in Pharmaceutics/ Pharmacology/ Pharmaceutical Technology as JRF, SRF in NIPER

National Institute of Pharmaceutical Education and Research (NIPER) is the first national level institute in pharmaceutical sciences with a proclaimed objective of becoming a centre of excellence for advanced studies and research in pharmaceutical sciences. The Government of India has declared NIPER as an 'Institute of National Importance'. It is an autonomous body set up under the aegis of Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India. The Institute is conceived to provide leadership in pharmaceutical sciences and related areas not only within the country, but also to the countries in South East Asia, South Asia and Africa. NIPER is a member of Association of Indian Universities and Association of Commonwealth Universities.

Walk in Interview will be held on 30.07.2014 at 10.00 am in the Conference Room, Secretariat Building of NIPER for temporary positions under following projects:

Seminar on Formulation Development of Liquid Oral Dosage Forms 6th June, 2014 at NIPER

NIPER had successfully conducted 53 training programs under the World Bank sponsored “Capacity Building Project” in the years 2004 to 2008. These were meant for the technical staff from government testing laboratories, regulatory bodies, private testing laboratories and analytical as well as production staff from Small and Medium Pharmaceutical Industries (SMPIs).

Applications are invited for the post of Junior Research Fellow/Project Assistant in National Agri-Food Biotechnology Institute

National Agri-Food Biotechnology Institute (NABI), Mohali, is an autonomous R&D Institute under the Department of Biotechnology, Government of India. The institute carries out cutting edge research at the interface of food, nutrition and agricultural biotechnology.

Applications are invited for the temporary position of a Junior Research Fellow (JRF)/Project Assistant under a DST sponsored research project in the Postharvest Biotechnology Research Programme at NABI.

Post: Junior Research Fellow (JRF)/Project Assistant

Opening to work as Pharmacists (3 post) in Ex-Serviceman Contributory Health Scheme

Retired Armed Forces personnel till 2002 could avail medical facilities only for specific high cost surgery/treatment for a limited number of diseases covered under the Army Group Insurance(Medical Branch Scheme) (AGI(MBS)) and Armed Forces Group Insurance Scheme(Management Information System) (AFGIS (MIS)) schemes. These medicare schemes could provide some relief to the ESM, but it was not a comprehensive scheme as compared to and available for other Central Government Employees. Therefore, the requirement was felt of establishing a medicare system which could provide quality medicare to the retirees of the Armed Forces.

ECHS invites applications to engage following staff on contractual basis in ECHS polyclinic under AOR of station headquarters chandimandir for a period of one year, renewable for addtional period:

Post: Pharmacist

Career for Fresh Trainee Scientific Officer in Panacea Biotec

Panacea Biotec is a leading research based Health Management Company, with an annual turnover of approx. Rs. 830 Crores. We are engaged in research, development, manufacture & marketing of Vaccines, Bio-Pharmaceuticals and Pharmaceuticals (Rx & OTC) of international quality and Health Services. All Panacea Biotec plants are accredited by international agencies and they follow current Good Manufacturing Practices, as per WHO guidelines.We offer stimulating work environment & a career that spells growth. In tune with our plans, we require young, aggressive, dynamic, high performing and result oriented professional.

Post: Trainee Scientific Officer

Work as Research Chemist in Panacea Biotec

Panacea Biotec is a leading research based Health Management Company, with an annual turnover of approx. Rs. 830 Crores. We are engaged in research, development, manufacture & marketing of Vaccines, Bio-Pharmaceuticals and Pharmaceuticals (Rx & OTC) of international quality and Health Services. All Panacea Biotec plants are accredited by international agencies and they follow current Good Manufacturing Practices, as per WHO guidelines.
We offer stimulating work environment & a career that spells growth. In tune with our plans, we require young, aggressive, dynamic, high performing and result oriented professional.

Post: Research Chemist

Work for Research Associate in Panacea Biotec

Panacea Biotec is a leading research based Health Management Company, with an annual turnover of approx. Rs. 830 Crores. We are engaged in research, development, manufacture & marketing of Vaccines, Bio-Pharmaceuticals and Pharmaceuticals (Rx & OTC) of international quality and Health Services. All Panacea Biotec plants are accredited by international agencies and they follow current Good Manufacturing Practices, as per WHO guidelines.
We offer stimulating work environment & a career that spells growth. In tune with our plans, we require young, aggressive, dynamic, high performing and result oriented professional.

Post: Research Associate

Walk in Interview from NIPER for the post of Junior Research Fellow

National Institute of Pharmaceutical Education and Research (NIPER) is the first national level institute in pharmaceutical sciences with a proclaimed objective of becoming a centre of excellence for advanced studies and research in pharmaceutical sciences. The Government of India has declared NIPER as an 'Institute of National Importance'. It is an autonomous body set up under the aegis of Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India. The Institute is conceived to provide leadership in pharmaceutical sciences and related areas not only within the country, but also to the countries in South East Asia, South Asia and Africa. NIPER is a member of Association of Indian Universities and Association of Commonwealth Universities.

The following position is available in Project No. GP-396 entitled, “Stereoselective Synthesis of Chiral Alcohols of Pharmaceutical Importance via Microbial Oxidoreductases: Process Development and Scale-up” sponsored by Ministry of Science and Technology, Department of Biotechnology, New Delhi in the Department of Pharmaceutical Technology (Biotechnology).

Post: Junior Research Fellow

Applications are invited for Research Assistant from M.S. (Pharm.)/M. Pharm/M.Sc in National Institute of Pharmaceutical Education and Research

The National Institute of Pharmaceutical Education and Research has been established under the aegis of Ministry of Chemicals and Fertilizers, Government of India, Dept. of Pharmaceuticals as a Centre of Excellence in imparting higher education, research and development in pharmaceutical sciences and is the first Institute of its kind in country. The Institute was declared as an Institute of National Importance by Government of India through an Act of Parliament, notified on 26th June 1998. The Institute is a member of the Association of Indian Universities and Association of Commonwealth Universities.

Post: Research Assistant

VON HIPPEL-LINDAU (VHL) SYNDROME: A CRITICAL INSIGHT

{ DOWNLOAD AS PDF }

About Authors:
Tapan Behl*, Ishneet Kaur, Puneet Sudan, Monika Sharma, Dr. Heena Goel
Assistant Professor, Department of Pharmacology,
Doaba Group of Colleges, Kharar, Mohali
tapanbehl31@gmail.com

Abstract:
Von Hippel-Lindau (VHL) syndrome is a rare genetic neoplastic disorder, arising from germline mutations in the VHL gene, characterized by the development of visceral cysts, specific benign and malignant tumors in multiple organ systems that have subsequent potential for spiteful change. It is caused by point mutations or deletions in a tumor suppressor gene. A tumor suppressor gene is the one which keeps cells from growing and dividing too rapidly in an uncontrolled way. Mutations in this gene prevent production of the VHL protein or lead to the production of an abnormal version of the protein. An altered or missing VHL protein cannot effectively regulate cell survival and division. As a result, cells grow and divide uncontrollably to form tumors and cysts that are characteristic of Von Hippel-Lindau syndrome. Although there is great variation in the clinical presentation, those who have a mutated gene are at greatly increased risk of developing spinal hemangioblastoma, renal cell carcinoma (RCC), retinal hemangioblastoma, cerebellar  hemangioblastoma, pheochromocytoma, pancreatic and renal cysts, endolymphatic  sac tumors, hemangiomas of the adrenals, liver and lungs, and papillary cystadenoma of the epididymis or broad ligament. The age at which the tumors present ranges from early childhood to the seventh decade of life. Early diagnosis, screening of family members and lifelong surveillance of VHL patients is recommended.

Pages